About our research
Lung Foundation Australia work across many areas in research and advocate in Government and with other funders to increase the funding allocated to lung disease research in Australia.
Research into Lung Disease… What’s Lung Foundation Australia doing?
In 2016, we funded 29 research projects that studied both respiratory and thoracic oncology conditions.
We increased our investment in lung research by 47% from 2015 and in 2016 our total research investment reached a significant milestone of $2.25 million. This funding is awarded by an expert panel of judges to universities, graduates, PhD students, and health professionals wanting to pursue research in lung disease.
We know funding for research into lung disease within Australia remains very low when you compare the funding to the impact of these lung conditions. Therefore, the Foundation is working hard to increase our funding for lung research over the next four years and aim to be investing $5million a year by 2020.
Our priority areas provide focus for our research strategy
Lung Foundation Australia raises funds to support research into the cause, treatment and cure of the numerous lung conditions within Australia. The Foundation has identified the following areas as our research priorities:
- chronic obstructive pulmonary disease (COPD)
- lung cancer/mesothelioma
- idiopathic pulmonary fibrosis (IPF)
- children’s rare lung diseases
We fund or facilitate research that is making a difference
- Dr Christian Osadnik (Monash University, VIC) started his two year Fellowship research project that aims to identify important COPD patient-related factors that will help determine who has a greater or lesser need for future rehabilitation strategies after hospitalisation due to acute COPD exacerbations or ‘flare-ups’.
- Dr Pei Ding (Ingham Institute of Applied Medial Research, NSW) is researching the development of ‘liquid biopsy’ with a simple blood test for lung cancer patients with EGRF mutation, to find out the genetic changes for this cancer without one having to have a tissue biopsy. This research is also to understand why and how lung cancer cells stop responding to current anticancer treatments.
- Dr Yet Hong Khor (Austin Health, VIC) is researching Oxidative Stress in Idiopathic Pulmonary Fibrosis patients to understand the safety of using oxygen therapy in people with IPF and aims to fill the gaps in our knowledge of oxygen therapy in people with IPF and might change current prescribing practice.
Investigator-led Trials Groups
Lung Foundation Australia has established two lung cancer investigator-led research trials groups that facilitate and conduct world-class multi-disciplinary research for disease understanding and management.
Our Research Reports
Lung Disease Research is vital and so is informing our community what we’ve been doing in research. We are currently pulling together a research report that will highlight the research we have funded or that has happened because of our research platforms (registries/trials groups) including the outcomes that are helping people live better with their lung condition.
Find out this year’s highlights from our research program and read more about the incredible work of our researchers and the research we enable.
Click on the flyer below for a full list of the 2016 and 2017 Research Award recipients:
ALTG 10 years report
The ALTG Management Advisory Committee released its first report in 2016 and is an overview of the ALTG’s growth and development since its inception in 2004. Click here.